Vaccines, blood, antisera, toxins and cultures in   Kenya

Exports In 2022, Kenya exported $5.22M in Vaccines, blood, antisera, toxins and cultures, making it the 82nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 146th most exported product in Kenya. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Kenya are: Sudan ($2.08M), Guyana ($1.35M), Uganda ($745k), Tanzania ($290k), and South Sudan ($141k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Kenya between 2021 and 2022 were Sudan ($1.67M), Tanzania ($67.1k), and Mali ($55.5k).

Imports In 2022, Kenya imported $147M in Vaccines, blood, antisera, toxins and cultures, becoming the 87th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 25th most imported product in Kenya. Kenya imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($51.9M), India ($45.6M), France ($8.29M), Belgium ($6.17M), and Italy ($5.55M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Kenya between 2021 and 2022 were India ($24.6M), United States ($11.4M), and Italy ($3.2M).